Glutathione reduced ethyl ester
CAS: 118421-50-4
Rif. 3D-FG03344
1g | 693,00 € | ||
2g | 1.071,00 € | ||
5g | 2.142,00 € | ||
250mg | 297,00 € | ||
500mg | 450,00 € |
Informazioni sul prodotto
- GSH-MEE Glutathione Monoethyl Ester gamma-Glu-Cys-Gly-OEt
- Glutathione monoethyl ester
- Glycine, <span class="text-smallcaps">L</smallcap>-γ-glutamyl-<smallcap>L</span>-cysteinyl-, monoethyl ester
- Glycine, N-(N-<span class="text-smallcaps">L</smallcap>-γ-glutamyl-<smallcap>L</span>-cysteinyl)-, monoethyl ester
- Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)-, monoethyl ester
- Ione Ethyl Ester
- N-(N-L-gamma-Glutamyl-L-cysteinyl)glycine monoethyl ester
- ethyl L-gamma-glutamyl-L-cysteinylglycinate
- Glycine, N-(N-L-γ-glutamyl-L-cysteinyl)-, monoethyl ester
- Glycine, L-γ-glutamyl-L-cysteinyl-, monoethyl ester
- Vedi altri sinonimi
Glutathione reduced ethyl ester (GR-E) is a potential anticancer drug that binds to the DNA and induces reactive oxygen species. GR-E has been shown to have minimal toxicity in vivo, with no observable adverse effects on the liver. GR-E has also been shown to be effective in treating squamous cell carcinoma cells by binding to their DNA and inducing apoptosis. This drug had minimal toxicity in animal studies, with no observable adverse effects on the liver. GR-E has been shown to be effective in treating squamous cell carcinoma cells by binding to their DNA and inducing apoptosis. This drug had minimal toxicity in animal studies, with no observable adverse effects on the liver. GR-E has also been shown to bind to toll-like receptor 2, which may lead to an antiinflammatory response.
Proprietà chimiche
Richiesta tecnica su: 3D-FG03344 Glutathione reduced ethyl ester
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.